Alteogen overtakes EcoPro BM, South Korea’s largest producer of cathodes for EV batteries, to become the biggest company on the Kosdaq by market capitalization.

Korean drug developer Chong Kun Dang on Monday said it has signed a W1.7 trillion out-licensing deal with global pharma giant Novartis (US$1=W1,297). This is the biggest technology transfer ...

and the raiding of Novartis Korea offices in relation to potential kickbacks paid to doctors in order to increase drug sales. Novartis' relationship with Alp Aydin had already highlighted ...

They also account for more than 60 percent of the executive-level employees at Lily Korea and Novartis Korea. Industry kingpin Pfizer is lower on the list with 40 percent of its executive ...

Biopharmaceutical company Celltrion has faced down the threat of a preliminary injunction of its biosmilar drug Omlyclo in an ...

Kisqali, a key targeted therapy for breast cancer from Novartis, until now has been indicated only for patients with metastatic disease. But on Tuesday, the Food and Drug Administration approved ...

The mainstay of therapy for the rare blood disease paroxysmal nocturnal hemoglobinuria (PNH) is Alexion's infusion therapy Soliris, but Novartis ... University in South Korea, the new trial's ...

The breast cancer drug Kisqali has received FDA approval to reduce cases of cancer recurrence. The drug was found to reduce ...

Milan Jaros / Bloomberg via Getty Images Novartis said its Kisqali breast cancer drug produced longer success for those with certain forms of the disease. The drug maker reported Kisqali along ...

Novartis NVS announced positive data on the cholesterol drug Leqvio (inclisiran) from the late-stage V-MONO study. Leqvio is ...

Travis King, the U.S. Army private who ran across the border from South Korea to North Korea last year, pleaded guilty on Friday. In a significant show of defiance against the United States ...